Using the body's mechanisms to degrade proteins not amenable to traditional small molecule approaches, offering the potential to "drug the undruggable" and permanently destroy target proteins.

Four protocols for bioprinting alginate using the Allevi by 3D Systems Platform.

The oracle company will partner with the FDA and John Snow Labs to develop natural language processing backed up by AI to study drug safety.

Key opinion leaders discuss how to approach challenges and opportunities which arise when looking to optimise lab processes.

Investigating the mysteries of proteins considered undruggable to expand the druggable genome.

Robot healthcare assistants designed to operate in outer space may sound like science fiction, but the reality is incredibly feasible. In this Commentary article, Daniel Leidner explains how telerobotics-enabled hardware is currently being trialled in different laboratory environments as a means of providing remote healthcare.

We hear the opinions of organ modelling experts on navigating three concepts which are critical to the field: complexity, robustness, and reproducibility.

In this Insight article, we explore SiLA: the consortium for Standardisation in Lab Automation, and look at some of the opportunities and challenges presented in the vision for a fully integrated laboratory environment.

AstraZeneca have been using the technology to evaluate drug-induced nephrotoxic effects

Cell-based therapies are a rapidly growing area of research with great promise.

Drug discovery experts join Oxford Global’s Neuroscience Drug Discovery and Development discussion group.